tiprankstipranks
Neurobiological Technologies Inc (NTII)
OTHER OTC:NTII
US Market
NTII
Neurobiological Technologies
RESEARCH TOOLSreports

Neurobiological Technologies (NTII) Financial Statements

1 Followers

Neurobiological Technologies Financial Overview

Neurobiological Technologies's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Neurobiological Technologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 09Jun 08Jun 07Jun 06Jun 05
Income Statement
Total Revenue
Gross Profit$ 26.35M$ 14.76M---
Operating Income$ 3.68M$ -16.70M$ -15.60M$ -16.44M$ -12.58M
EBITDA$ 3.25M$ -16.49M$ -15.37M$ -16.24M$ -12.48M
Net Income$ 3.12M$ -16.32M$ -14.13M$ -27.84M$ -24.98M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 24.66M$ 43.19M$ 10.92M$ 22.50M$ 9.81M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -24.05M$ -29.98M$ -8.90M$ -15.25M$ -8.51M
Total Liabilities$ 1.11M$ 22.90M$ 33.01M$ 33.90M$ 3.82M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -16.43M$ -20.71M$ -13.22M$ 8.65M$ -10.05M
Operating Cash Flow$ -16.43M$ -20.70M$ -13.15M$ 9.00M$ -9.40M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Neurobiological Technologies Earnings and Revenue History

Income Statement >

Neurobiological Technologies Debt to Assets

Balance Sheet >

Neurobiological Technologies Cash Flow

Cash Flow >

Neurobiological Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >